The Central Florida-based clinical research organization brings decades of experience, strong enrollment, and community-centered research to hyperCORE's expanding global network
LAKE MARY, FL, April 23, 2026 /24-7PressRelease/ -- hyperCORE International is pleased to welcome Optimal Research Sites, based in Central Florida, to its global partner site network as the organization continues to expand its capabilities and patient reach across key U.S. markets.
Optimal Research Sites brings more than 30 years of experience conducting Phase I–IV clinical trials, with a long-standing reputation for reliable enrollment, diverse patient access, and consistent operational excellence. The organization is rooted in strong relationships with their surrounding community as well as sponsors, supporting a wide range of clinical research initiatives while maintaining a personalized, patient-focused approach.
Joining hyperCORE enhances Optimal Research Sites' ability to collaborate across a network of high-performing research organizations, enabling the exchange of operational best practices and continuous quality improvement. Through a unified network model, the organization benefits from more streamlined communication with sponsors and CROs, while expanding study opportunities through broader geographic reach and therapeutic capabilities.
"hyperCORE's network offers a compelling strategic step for our organization as we continue to grow, while also providing the ability to maintain the standards that have defined our work for decades," said Claxton Copeland, Director & Site Owner at Optimal. "The opportunity to collaborate with like-minded research organizations, share best practices, and expand access to clinical trials strengthens our ability to deliver for both sponsors and our community."
"Optimal Research Sites brings a strong foundation of experience, consistency, and community engagement to our partner network," said Nicholas Focil, President of hyperCORE International. "Their track record in delivering high-quality trials, depth of trial experience, and commitment to patient access align closely with hyperCORE's mission, and we are pleased to welcome them to our partner site network."
hyperCORE International is a partner site network of leading independent clinical research organizations, with more than 80 active trial sites across the US. Collectively, hyperCORE partners have completed over 10,000 studies involving more than 150,000 randomized participants. The network aligns multi-specialty research site organizations around harmonized operational frameworks that support high-quality, consistent trial execution.
hyperCORE is committed to advancing clinical research through safe, ethical studies, strong enrollment, and superior patient retention.
---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
